Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.74 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.74 |
| ▸ | MAPT | P10636 | 7/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.63 |
| ▸ | RXRA | P19793 | 5/20 | 0.63 |
| ▸ | RARA | P10276 | 4/20 | 0.63 |
| ▸ | RARB | P10826 | 4/20 | 0.63 |
| ▸ | RARG | P13631 | 4/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.63 |
| ▸ | APP | P05067 | 4/20 | 0.63 |
| ▸ | SNCA | P37840 | 4/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.63 |
| ▸ | RXRB | P28702 | 2/20 | 0.63 |
| ▸ | RXRG | P48443 | 2/20 | 0.63 |
| ▸ | RORC | P51449 | 2/20 | 0.63 |
| ▸ | HTR2B | P41595 | 2/20 | 0.63 |
| ▸ | BLM | P54132 | 2/20 | 0.63 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.63 |
| ▸ | DRD3 | P35462 | 2/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2006702 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ADORA3MAPTCYP3A4RXRA | |
| SCHEMBL1895263 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ADORA3MAPTCYP3A4RXRA | |
| SCHEMBL2008326 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ADORA3MAPTCYP3A4RXRA | |
| SCHEMBL57568 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ADORA3MAPTCYP3A4RXRA | |
| SCHEMBL1695153 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ADORA3MAPTCYP3A4RXRA | |
| SCHEMBL4399478 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ADORA3MAPTCYP3A4RXRA | |
| SCHEMBL2011547 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ADORA3MAPTCYP3A4RXRA | |
| SCHEMBL2005744 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ADORA3MAPTCYP3A4RXRA | |
| SCHEMBL2005804 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ADORA3MAPTCYP3A4RXRA | |
| SCHEMBL2008700 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ADORA3MAPTCYP3A4RXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118251350-A | Double unit package | 联合利华知识产权控股有限公司 | 2024-06-25 | — | — | CN | claimed |
| EP-2869717-B1 | PREVENTION OF ALCOHOL REACTION WITH DIETARY SUPPLEMENTS | NOGLO LLC (US) | 2018-06-13 | — | — | EP | claimed |
| EP-2869717-A1 | PREVENTION OF ALCOHOL REACTION WITH DIETARY SUPPLEMENTS | Tolleth, Robert J. (US) | 2015-05-13 | — | — | EP | claimed |
| WO-2014143192-A1 | REDUCTION OR PREVENTION OF ALCOHOL REACTION WITH DIETARY SUPPLEMENTS | NOGLO LLC (US) | 2014-09-18 | — | — | WO | claimed |
| US-20140256760-A1 | REDUCTION OR PREVENTION OF ALCOHOL REACTION WITH DIETARY SUPPLEMENTS | NOGLO LLC (US) | 2014-09-11 | — | — | US | claimed |
| US-20140045874-A1 | PREVENTION OF ALCOHOL REACTION WITH DIETARY SUPPLEMENTS | NOGLO LLC (US) | 2014-02-13 | — | — | US | claimed |
| WO-2014011676-A1 | PREVENTION OF ALCOHOL REACTION WITH DIETARY SUPPLEMENTS | TOLLETH ROBERT J (US) | 2014-01-16 | — | — | WO | claimed |
| US-20080287393-A1 | External Skin Composition | KAO CORPORATION (JP) | 2008-11-20 | — | — | US | claimed |
| US-20050002879-A1 | External skin compositions | KAO CORPORATION (JP) | 2005-01-06 | — | — | US | claimed |
| CN-118251350-A | Double unit package | 联合利华知识产权控股有限公司 | 2024-06-25 | — | — | CN | disclosed |
| WO-2024099690-A1 | A PERSONAL CARE COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2024-05-16 | — | — | WO | disclosed |
| EP-4351513-A1 | SKIN CARE COMPOSITION | Unilever IP Holdings B.V. (NL) | 2024-04-17 | — | — | EP | disclosed |
| CN-117460492-A | Skin care composition | 联合利华知识产权控股有限公司 | 2024-01-26 | — | — | CN | disclosed |
| WO-2023099130-A1 | PERSONAL CARE COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2023-06-08 | — | — | WO | disclosed |
| US-20010049365-A1 | Vitamin D analog and a retinoid, wherein: the retinoid is 4-oxo-retinol, 4-oxo- retinal, or 4-oxo-retinyl ester; also restoring the natural color of gray hair; treating hair and skin disorders | LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) | 2001-12-06 | — | — | US | disclosed |
| WO-2001043711-A1 | COSMETIC SKIN CONDITIONING COMPOSITIONS CONTAINING RED YEAST RICE EXTRACT | UNILEVER PLC (GB) | 2001-06-21 | — | — | WO | disclosed |
| EP-1104294-A1 | COMPOSITIONS AND METHODS OF TREATING ABNORMAL CELL PROLIFERATION | Achkar, Charles C. (US) | 2001-06-06 | — | — | EP | disclosed |
| US-6242435-B1 | VITAMIN D ANALOG AND A RETINOID | GENTRIX LLC | 2001-06-05 | — | — | US | disclosed |
| US-20010002396-A1 | COMPOSITIONS AND METHODS OF TREATING SKIN CONDITIONS | GENTRIX LLC | 2001-05-31 | — | — | US | disclosed |
| WO-2000003700-A1 | COMPOSITIONS AND METHODS OF TREATING ABNORMAL CELL PROLIFERATION | ACHKAR CHARLES C (US) | 2000-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010049365-A1 | Vitamin D analog and a retinoid, wherein: the retinoid is 4-oxo-retinol, 4-oxo- retinal, or 4-oxo-retinyl ester; also restoring the natural color of gray hair; treating hair and skin disorders | RBP4, VDR, CYP24A1 | ALDH1A1 234/4885ADORA3 430/4885MAPT 4178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.